SE439586B - Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat - Google Patents

Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat

Info

Publication number
SE439586B
SE439586B SE7609443A SE7609443A SE439586B SE 439586 B SE439586 B SE 439586B SE 7609443 A SE7609443 A SE 7609443A SE 7609443 A SE7609443 A SE 7609443A SE 439586 B SE439586 B SE 439586B
Authority
SE
Sweden
Prior art keywords
dehydroepiandrosteron
sulphate
prepare
stable pharmaceutical
dry preparation
Prior art date
Application number
SE7609443A
Other languages
English (en)
Swedish (sv)
Other versions
SE7609443L (sv
Inventor
I Sugimoto
Y Sawase
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50108197A external-priority patent/JPS5231821A/ja
Priority claimed from JP8061376A external-priority patent/JPS537662A/ja
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of SE7609443L publication Critical patent/SE7609443L/
Publication of SE439586B publication Critical patent/SE439586B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE7609443A 1975-09-05 1976-08-26 Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat SE439586B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50108197A JPS5231821A (en) 1975-09-05 1975-09-05 Method of manufacturing freeze-dried dehydroepiandrosterone sulfate sa lts for injection use
JP8061376A JPS537662A (en) 1976-07-06 1976-07-06 Preparation of injection containing stable dehydroepiandrosterone sulfate

Publications (2)

Publication Number Publication Date
SE7609443L SE7609443L (sv) 1977-03-06
SE439586B true SE439586B (sv) 1985-06-24

Family

ID=26421606

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609443A SE439586B (sv) 1975-09-05 1976-08-26 Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat

Country Status (15)

Country Link
US (1) US4061744A (fr)
AU (1) AU498543B2 (fr)
CA (1) CA1047404A (fr)
CS (1) CS216160B2 (fr)
DD (1) DD127381A5 (fr)
DE (1) DE2639849C2 (fr)
DK (1) DK153124C (fr)
ES (1) ES451256A1 (fr)
FR (1) FR2322605A1 (fr)
GB (1) GB1561360A (fr)
HU (1) HU173475B (fr)
IL (1) IL50376A (fr)
NL (1) NL183385C (fr)
SE (1) SE439586B (fr)
SU (1) SU1072789A3 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
JP2546808B2 (ja) * 1989-01-23 1996-10-23 鐘紡株式会社 膣坐剤
US5246704A (en) * 1989-01-23 1993-09-21 Kanebo, Ltd. Vaginal suppository
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
CA2013474C (fr) * 1989-04-20 2000-01-18 Pharmacia Inc. Lyophilisats de cyclophosphamide et d'alanine
US5268368A (en) * 1991-05-17 1993-12-07 Erbamont, Inc. Cyclophosphamide--amino acid lyophilizates
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957392A (en) * 1961-07-17 1964-05-06 Farmaceutici Italia 16ª‡-hydroxy-steroids
DE1767898A1 (de) * 1967-07-28 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung einer Arzneimittelzubereitung
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin

Also Published As

Publication number Publication date
DD127381A5 (fr) 1977-09-21
NL183385C (nl) 1988-10-17
DK153124C (da) 1988-12-19
ES451256A1 (es) 1977-09-16
SE7609443L (sv) 1977-03-06
DK396576A (da) 1977-03-06
AU498543B2 (en) 1979-03-15
NL7609833A (nl) 1977-03-08
DK153124B (da) 1988-06-20
GB1561360A (en) 1980-02-20
SU1072789A3 (ru) 1984-02-07
DE2639849C2 (de) 1987-02-12
CA1047404A (fr) 1979-01-30
DE2639849A1 (de) 1977-03-17
FR2322605B1 (fr) 1982-08-20
US4061744A (en) 1977-12-06
AU1748676A (en) 1978-03-16
IL50376A (en) 1979-10-31
FR2322605A1 (fr) 1977-04-01
IL50376A0 (en) 1976-10-31
HU173475B (hu) 1979-05-28
CS216160B2 (en) 1982-10-29
NL183385B (nl) 1988-05-16

Similar Documents

Publication Publication Date Title
SE420204B (sv) Sett att framstella sulfonsyrasalter av s-adenosylmetionin
SE385687B (sv) Sett att framstella en stabil losning av basiskt aluminiumsalt
SE439485B (sv) Sett att framstella nya alkyloximderivat av 7-aminotiazolyl-acetamidocefalosporansyra
SE7600277L (sv) Sett att framstella sampolymerisatpulver
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
SE440655B (sv) Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra
SE436469B (sv) Sett att framstella overdragna granuler av alkalimetallsalter av polyakrylsyra
SE432727B (sv) Sett att tillverka en form for en gjuten produkt
SE439586B (sv) Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
NO151360C (no) Sementblanding inneholdende et retarderingsmiddel paa basis av lignosulfonat eller et alkalimetallsaltderivat derav
SE427006B (sv) Sett att framstella frystorkat pulver innehallande prostaglandin
SE421989B (sv) Forfarande for framstellning av hardkarameller varvid en xylitolsmelta tillsettes xylitol i pulverform
SE7604890L (sv) Sett att framstella perkarbonsyralosningar
SE7510329L (sv) Framstellning av 5-fluoro-2-metyl-1-(p-metylsultinylbensyliden)-indenyl-3-ettiksyra
SE419223B (sv) Sett att framstella ett derivat av gentamin och dess syraadditionssalter
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE432726B (sv) Sett att tillverka en keramisk form for noggrann formning av en gjuten produkt
SE418573B (sv) Sett att framstella ett vaccin
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE429866B (sv) Sett att framstella karbamater av metylfosfonsyradietylester
SE432588B (sv) Sett att framstella substituerade fenyl-alkyl-karboxylsyror
SE7811704L (sv) Framstellning av 1-hydrokarbylpyrrol-2-ettiksyraderivat
SE7601836L (sv) Forfarande for framstellning av ett dimerkaptoeltyleterderivat
SE384365B (sv) Sett att framstella ett farmaceutiskt anvendbart kalciumsalt av 6-acetyl-amino-hexansyra

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7609443-2

Format of ref document f/p: F